Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Open-Label Extension in Painful Diabetic Peripheral Neuropathy
NCT00150423Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Pfizer. Started Jan 2001; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00150423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150423.